High Hampton Holdings Corp Stock Canadian Securities Exchange
Equities
CA42966X2005
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 563K 411K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 841K 614K | Net cash position 2023 | 690K 504K | EV / Sales 2023 | - |
P/E ratio 2022 |
22.9
x | P/E ratio 2023 |
-8.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.53% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Dubeau
CEO | Chief Executive Officer | - | 23-09-25 |
Director of Finance/CFO | 53 | 23-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 53 | 23-09-18 | |
Robert Dubeau
CEO | Chief Executive Officer | - | 23-09-25 |
Anderson Shannon
BRD | Director/Board Member | - | 23-09-18 |
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |